Literature DB >> 3044821

Bone marrow transplantation for myeloblastoma.

K Quabeck1, D W Beelen, H K Mahmoud, H G Sayer, U Graeven, U W Schaefer, C G Schmidt, D K Hossfeld.   

Abstract

A 20-yr-old man with bulky mediastinal and retroperitoneal tumour masses identified as myeloblastoma is described. After a partial remission was induced by aggressive chemotherapy, mediastinal irradiation and retroperitoneal tumour resection, the patient received an allogeneic marrow graft from his HLA-identical sister. The conditioning regimen consisted of high-dose busulfan and cyclophosphamide. The patient has a well-controlled secondary chronic graft-versus-host disease. He is in unmaintained complete remission and in good general condition at 20 months post-transplantation.

Entities:  

Mesh:

Year:  1988        PMID: 3044821     DOI: 10.1111/j.1600-0609.1988.tb00890.x

Source DB:  PubMed          Journal:  Eur J Haematol        ISSN: 0902-4441            Impact factor:   2.997


  2 in total

1.  Refractory de novo myeloid sarcoma: a case report and therapeutic strategy based on bone marrow minimal residual disease.

Authors:  Daichi Inoue; Yuya Nagai; Takaharu Kimura; Sonoko Shimoji; Minako Mori; Katsuhiro Togami; Sumie Tabata; Masayuki Kurata; Akiko Matsushita; Kiminari Ito; Hisako Hashimoto; Hayato Maruoka; Eiko Yamashita; Kenichi Nagai; Yukihiro Imai; Hirohumi Shirane; Takayuki Takahashi
Journal:  Int J Hematol       Date:  2009-06-10       Impact factor: 2.490

2.  Isolated granulocytic sarcoma of the small intestine successfully treated with chemotherapy and bone marrow transplantation.

Authors:  Yukiko Kitagawa; Yuichi Sameshima; Hiroko Shiozaki; Shinpei Ogawa; Akihiro Masuda; Shin-Ichiro Mori; Masanao Teramura; Michihiko Masuda; Shingo Kameoka; Toshiko Motoji
Journal:  Int J Hematol       Date:  2008-05       Impact factor: 2.490

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.